142 related articles for article (PubMed ID: 37607071)
21. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma.
Xu F; Liu Z; Liu R; Lu C; Wang L; Mao W; Zhu Q; Shou H; Zhang K; Li Y; Chu Y; Gu J; Ge D
Cell Commun Signal; 2020 Feb; 18(1):17. PubMed ID: 32014008
[TBL] [Abstract][Full Text] [Related]
24. [SERPINE2 promotes cellular migration and invasion in esophageal squamous cell carcinoma by activating β-catenin].
Zhang JL; Luo AP; Huang FR; Gong TY; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):638-645. PubMed ID: 34289555
[No Abstract] [Full Text] [Related]
25. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
[TBL] [Abstract][Full Text] [Related]
26. ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription.
Jiang H; Du M; Li Y; Zhou T; Lei J; Liang H; Zhong Z; Al-Lamki RS; Jiang M; Yang J
Cell Death Dis; 2022 Jun; 13(6):549. PubMed ID: 35701409
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD44 and CD133 stem cell markers in squamous cell carcinoma of esophagus.
Gupta P; Rizvi SZ; Lal N; Gupta V; Srivastav AN; Musa O
Indian J Pathol Microbiol; 2021; 64(3):472-478. PubMed ID: 34341256
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks.
Liang M; Pan Z; Yu F; Chen C
Clin Transl Oncol; 2020 Oct; 22(10):1786-1795. PubMed ID: 32086782
[TBL] [Abstract][Full Text] [Related]
29. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
31. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
[TBL] [Abstract][Full Text] [Related]
32. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.
Patel D; Chaudhary J
Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737
[TBL] [Abstract][Full Text] [Related]
34. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
35. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma.
Khales SA; Mozaffari-Jovin S; Geerts D; Abbaszadegan MR
BMC Cancer; 2022 Dec; 22(1):1272. PubMed ID: 36474162
[TBL] [Abstract][Full Text] [Related]
36. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
Wang C; Cheng L; Song S; Wu S; Sun G
J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.
Jiang W; Yao F; He J; Lv B; Fang W; Zhu W; He G; Chen J; He J
Tumour Biol; 2015 Feb; 36(2):1289-97. PubMed ID: 25352025
[TBL] [Abstract][Full Text] [Related]
38. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
39. Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.
Wang L; Xing J; Cheng R; Shao Y; Li P; Zhu S; Zhang S
PLoS One; 2015; 10(5):e0126319. PubMed ID: 25950810
[TBL] [Abstract][Full Text] [Related]
40. FOXD3 suppresses epithelial-mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma.
Wu Z; Li Y; Niu Y; Lu J; Yan Z; Xu T; Guo Y; Dong Z; Guo W
Mol Carcinog; 2021 Dec; 60(12):859-873. PubMed ID: 34551139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
